It has been reported that in high-risk for OHSS PCOS patients, the use of GnRH antagonists is associated with a significantly decreased incidence of OHSS by 20% compared to the use of the long GnRH agonist protocol[11]. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.